Yttrium-90 radiosynovectomy in knees and ankles (25 joints in 22 hemophilic patients). Short-term results

The radiosynovectomy (RS) is one treatment option for recurrent hemarthrosis in patients with hemophilia (PWH). A prospective cohort study was designed to evaluate the effects of the RS on the synovial membrane volume in the ankles and knees of PWH and patient characteristics related to the RS outco...

Full description

Saved in:
Bibliographic Details
Published in:Hematology, Transfusion and Cell Therapy Transfusion and Cell Therapy, 2021-01, Vol.43 (1), p.15-20
Main Authors: Magalhães, Andréa Fernandes, de Oliveira, Luciana Correa O, Pitella, Felipe Arriva, Wichert-Ana, Lauro, Engel, Edgard Eduard, Barbieri, Cláudio Henrique
Format: Article
Language:eng ; por
Subjects:
Hemarthrosis
Hemophilic arthropathy
Image analysis
Magnetic resonance imaging
MEDICINE, GENERAL & INTERNAL
Original
Radiosynoviorthesis
Synovitis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The radiosynovectomy (RS) is one treatment option for recurrent hemarthrosis in patients with hemophilia (PWH). A prospective cohort study was designed to evaluate the effects of the RS on the synovial membrane volume in the ankles and knees of PWH and patient characteristics related to the RS outcome. In a one-year follow-up, 25 joints of 22 PWH who presented 3 bleeds or more in the same joint over the last 6 months (target joints) were subjected to the RS. Two groups were compared: those who retained target joints following the RS and those who did not (less than 3 bleeds/6 months after the RS). The groups were analyzed according to age, hemophilia type/severity, joint, body mass index (BMI), inhibitor and Hemophilia Joint Health Score 2.1 (HJHS). The magnetic resonance images (MRI) of six ankles and six knees were acquired prior to, and 6 months after, the RS. The synovial membrane volume and arthropathy MRI scale were accessed and volumes were compared and correlated with the Yttrium-90 dose injected. Patients with a mean age of 12 years and a mean HJHS of 6.7 (p 
ISSN:2531-1379
2531-1387
2531-1387
DOI:10.1016/j.htct.2019.11.001